| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 318.907 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 384.68 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 258.76 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 296.136 | 87 |
| GSM780720 | Untreated after 4 days (C2_2) | 417.021 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 275.496 | 87 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 637.13 | 93 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1539.58 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1391.36 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 704.473 | 94 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1406.71 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1544.21 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1144.96 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 562.828 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1466.88 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1321.58 | 97 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 579.835 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1563.12 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 590.552 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 763.073 | 94 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 709.407 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 621.301 | 93 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 751.566 | 94 |